PAPER Valente S, Tomassi S, Tempera G, Saccoccio S, Agostinelli E, Mai A
SEARCH RESULTS
331209 RESULTS
PAPER Elmann A, Mordechay S, Erlank H, Telerman A, Rindner M, Ofir R
Anti-neuroinflammatory effects of the extract of Achillea fragrantissima.
BMC Complement Altern Med. 2011;11:98. PubMed: 22018032PAPER Jämsä A, Belda O, Edlund M, Lindström E
BACE-1 inhibition prevents the γ-secretase inhibitor evoked Aβ rise in human neuroblastoma SH-SY5Y cells.
J Biomed Sci. 2011;18:76. PubMed: 22018341PAPER Musiek ES, Chen Y, Korczykowski M, Saboury B, Martinez PM, Reddin JS, Alavi A, Kimberg DY, Wolk DA, Julin P, Newberg AB, Arnold SE, Detre JA
Direct comparison of fluorodeoxyglucose positron emission tomography and arterial spin labeling magnetic resonance imaging in Alzheimer's disease.
Alzheimers Dement. 2011 Oct 20; PubMed: 22018493PAPER Kantarci K, Lowe VJ, Boeve BF, Weigand SD, Senjem ML, Przybelski SA, Dickson DW, Parisi JE, Knopman DS, Smith GE, Ferman TJ, Petersen RC, Jack CR
Multimodality imaging characteristics of dementia with Lewy bodies.
Neurobiol Aging. 2011 Oct 20; PubMed: 22018896PAPER Yesil Y, Kuyumcu ME, Cankurtaran M, Uz B, Kara A, Kilic MK, Halil M, Ulger Z, Yavuz BB, Haznedaroğlu IC, Ariogul S
Increased mean platelet volume (MPV) indicating the vascular risk in Alzheimer's disease (AD).
Arch Gerontol Geriatr. 2011 Oct 20; PubMed: 22019010PAPER Marra C, Quaranta D, Profice P, Pilato F, Capone F, Iodice F, Di Lazzaro V, Gainotti G
Central cholinergic dysfunction measured "in vivo" correlates with different behavioral disorders in Alzheimer's disease and dementia with Lewy body.
Brain Stimul. 2011 Sep 15; PubMed: 22019082PAPER Samaroo HD, Opsahl AC, Schreiber J, O'Neill SM, Marconi M, Qian J, Carvajal-Gonzalez S, Tate B, Milici AJ, Bales KR, Stephenson DT
High throughput object-based image analysis of β-amyloid plaques in human and transgenic mouse brain.
J Neurosci Methods. 2012 Feb 15;204(1):179-88. PubMed: 22019329PAPER Huang W, Tang L, Shi Y, Huang S, Xu L, Sheng R, Wu P, Li J, Zhou N, Hu Y
Searching for the Multi-Target-Directed Ligands against Alzheimer's disease: discovery of quinoxaline-based hybrid compounds with AChE, H₃R and BACE 1 inhibitory activities.
Bioorg Med Chem. 2011 Dec 1;19(23):7158-67. PubMed: 22019465PAPER Schrag A, Schott JM,
What is the clinically relevant change on the ADAS-Cog?
J Neurol Neurosurg Psychiatry. 2012 Feb;83(2):171-3. PubMed: 22019547PAPER Lau AJ, Yang G, Rajaraman G, Baucom CC, Chang TK
Species-dependent and receptor-selective action of bilobalide on the function of constitutive androstane receptor and pregnane x receptor.
Drug Metab Dispos. 2012 Jan;40(1):178-86. PubMed: 22019630PAPER Mecocci P, Polidori MC
Antioxidant clinical trials in mild cognitive impairment and Alzheimer's disease.
Biochim Biophys Acta. 2011 Oct 13; PubMed: 22019723PAPER Wee CY, Yap PT, Zhang D, Denny K, Browndyke JN, Potter GG, Welsh-Bohmer KA, Wang L, Shen D
Identification of MCI individuals using structural and functional connectivity networks.
Neuroimage. 2012 Feb 1;59(3):2045-56. PubMed: 22019883PAPER Ahn HJ, Seo SW, Chin J, Suh MK, Lee BH, Kim ST, Im K, Lee JM, Lee JH, Heilman KM, Na DL
The cortical neuroanatomy of neuropsychological deficits in mild cognitive impairment and Alzheimer's disease: a surface-based morphometric analysis.
Neuropsychologia. 2011 Dec;49(14):3931-45. PubMed: 22019776PAPER Arold S, Sullivan P, Bilousova T, Teng E, Miller CA, Poon WW, Vinters HV, Cornwell LB, Saing T, Cole GM, Gylys KH
Apolipoprotein E level and cholesterol are associated with reduced synaptic amyloid beta in Alzheimer's disease and apoE TR mouse cortex.
Acta Neuropathol. 2012 Jan;123(1):39-52. Epub 2011 Oct 22 PubMed: 22020632Current Filters
No filters selected